JP2023542500A5 - - Google Patents
Info
- Publication number
- JP2023542500A5 JP2023542500A5 JP2023516250A JP2023516250A JP2023542500A5 JP 2023542500 A5 JP2023542500 A5 JP 2023542500A5 JP 2023516250 A JP2023516250 A JP 2023516250A JP 2023516250 A JP2023516250 A JP 2023516250A JP 2023542500 A5 JP2023542500 A5 JP 2023542500A5
- Authority
- JP
- Japan
- Prior art keywords
- saponin
- xyl
- rha
- fuc
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2026442 | 2020-09-10 | ||
| NL2026442 | 2020-09-10 | ||
| NL2027405 | 2021-01-26 | ||
| NL2027405A NL2027405B1 (en) | 2021-01-26 | 2021-01-26 | Semicarbazone-based saponin conjugate |
| PCT/NL2021/050384 WO2021261992A1 (en) | 2020-06-24 | 2021-06-18 | Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugate |
| NLPCT/NL2021/050384 | 2021-06-18 | ||
| PCT/NL2021/050549 WO2022055351A1 (en) | 2020-09-10 | 2021-09-09 | Conjugate of saponin, oligonucleotide and galnac |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542500A JP2023542500A (ja) | 2023-10-10 |
| JP2023542500A5 true JP2023542500A5 (https=) | 2024-09-02 |
Family
ID=85573705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516250A Pending JP2023542500A (ja) | 2020-09-10 | 2021-09-09 | サポニン、オリゴヌクレオチド、及びｇａｌｎａｃのコンジュゲート |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240327829A1 (https=) |
| EP (2) | EP4529953A3 (https=) |
| JP (1) | JP2023542500A (https=) |
| KR (1) | KR20230066384A (https=) |
| CN (1) | CN116437965A (https=) |
| AU (1) | AU2021339332A1 (https=) |
| CA (1) | CA3192469A1 (https=) |
| IL (1) | IL301214A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117244054B (zh) * | 2023-10-16 | 2024-06-07 | 国药中生生物技术研究院有限公司 | 具有螺甾烷-O-gal结构的化合物的佐剂用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1623715B1 (en) * | 2004-07-13 | 2012-09-19 | Charité - Universitätsmedizin Berlin | A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| WO2011054811A1 (en) * | 2009-11-03 | 2011-05-12 | Santaris Pharma A/S | Rna antagonists targeting hsp27 combination therapy |
| MX2016005855A (es) * | 2013-11-14 | 2016-07-13 | Roche Innovation Ct Copenhagen As | Compuestos de conjugados antisentido de apolipoproteina b (apob). |
| SG11202106603UA (en) * | 2018-12-21 | 2021-07-29 | Sapreme Tech Bv | Biologically active cluster of molecules |
-
2021
- 2021-09-09 JP JP2023516250A patent/JP2023542500A/ja active Pending
- 2021-09-09 EP EP25151594.6A patent/EP4529953A3/en active Pending
- 2021-09-09 CA CA3192469A patent/CA3192469A1/en active Pending
- 2021-09-09 EP EP21794416.4A patent/EP4210760B1/en active Active
- 2021-09-09 US US18/044,945 patent/US20240327829A1/en active Pending
- 2021-09-09 IL IL301214A patent/IL301214A/en unknown
- 2021-09-09 KR KR1020237011435A patent/KR20230066384A/ko active Pending
- 2021-09-09 AU AU2021339332A patent/AU2021339332A1/en active Pending
- 2021-09-09 CN CN202180070494.9A patent/CN116437965A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arima et al. | In vitro and in vivo gene delivery mediated by lactosylated dendrimer/α-cyclodextrin conjugates (G2) into hepatocytes | |
| US20070060499A1 (en) | Chloroquine combination drugs and methods for their synthesis | |
| TW202540423A (zh) | 用於抑制17β-HSD第13型(HSD17B13)表現之RNAi藥劑、其組合物及使用方法 | |
| JP2025041739A (ja) | 核酸、薬物組成物及び複合体ならびに調製方法と使用 | |
| EP3992290A1 (en) | Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof | |
| EP3978609A1 (en) | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | |
| CN110997919A (zh) | 双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途 | |
| US11485752B2 (en) | Modified oligonucleotides and compound that can be used for synthesizing same | |
| US20240307545A1 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| JP2023532040A5 (https=) | ||
| US20080051323A1 (en) | Chloroquine drug compositions and methods for their synthesis | |
| JP2024530839A5 (https=) | ||
| US20230277612A1 (en) | Saponin derivatives for use in medicine | |
| KR20230043114A (ko) | Galnac과 사포닌의 접합체, 상기 접합체 및 galnac-올리고뉴클레오티드 접합체를 포함하는 치료적 조성물 | |
| JP2023533693A5 (https=) | ||
| EP4635501A2 (en) | Saponin derivatives with improved therapeutic window | |
| JP2023542500A5 (https=) | ||
| JP2022542075A5 (https=) | ||
| US20060040879A1 (en) | Chloroquine coupled nucleic acids and methods for their synthesis | |
| EP4171643B1 (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| WO2023208109A1 (zh) | 用于抑制HSD17B13表达的siRNA、其缀合物和药物组合物及其用途 | |
| US20250320500A1 (en) | Nucleic acid, pharmaceutical composition and sirna conjugate containing the nucleic acid, preparation method therefor, and use thereof | |
| EP4210760B1 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| HK40128805A (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| HK40110483A (en) | Conjugate of saponin, oligonucleotide and galnac |